This is a preview of subscription content, log in via an institution to check access.
Notes
DRESS = drug reaction with eosinophilia and systemic symptoms
Reference
Government of Canada. Summary Safety Review - BRILINTA (ticagrelor) - Assessing the Potential Risk of Severe Skin Side Effects. Internet Document : 26 Jun 2017. Available from: URL: https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/safety-reviews/summary-safety-review-brilinta-assessing-potential-risk-severe-skin-side-effects.html
Rights and permissions
About this article
Cite this article
Use of ticagrelor linked with severe skin ADRs?. Reactions Weekly 1659, 4 (2017). https://doi.org/10.1007/s40278-017-32662-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-017-32662-1